Results 161 to 170 of about 15,205 (209)

Echocardiographic evaluation of the effects of sacubitril–valsartan on vascular properties in heart failure patients

, 2019
Ilya Karagodin, Sara Kalantari, Dongbo Yu, Gene Kim, Gabriel Sayer, Karima Addetia, Sarah Tayazime, Lynn Weinert, Megan Yamat, Nir Uriel, Roberto M. Lang, Victor Mor‐Avi   +11 more
openalex   +2 more sources

Sacubitril/valsartan preserves kidney function in rats with cardiorenal syndrome after myocardial infarction. [PDF]

PLoS One
Bergo KK, Nordén ES, Bendiksen BA, Espe EKS, McGinley G, Hauge-Iversen IM, Hussain RI, Leh S, Marti HP, Zhang L, Sjaastad I, Cataliotti A.   +11 more
europepmc   +1 more source

Correction: Single-Center Experience with Sacubitril/Valsartan in Patients with Congenital Heart Disease. [PDF]

Pediatr Cardiol
Konduri A, Duimstra A, Lowery R, Yu S, Huebschman A, Crandall B, Hunter T, Lim HM, McCormick AD, Schumacher KR, Peng DM.   +10 more
europepmc   +1 more source

Effect of Sacubitril/Valsartan, Ivabradine, and Captopril on Anxiety-like Behavior in Spontaneously Hypertensive Rats. [PDF]

Int J Mol Sci
Szighardtova M, Aziriova S, Stanko P, Repova K, Baka T, Krajcirovicova K, Zorad S, Adamcova M, Sabaka P, Borbélyová V, Simko F.   +10 more
europepmc   +1 more source

Effects and clinical implications of sacubitril/valsartan on left ventricular reverse remodeling in patients affected by chronic heart failure: A 24-month follow-up

, 2021
Carla Paolini, Giacomo Mugnai, Chiara Dalla Valle, Andrea Volpiana, Alessandra Ferraglia, Anna Chiara Frigo, Claudio Bilato   +6 more
openalex   +1 more source

Sacubitril/valsartan fails to prevent doxorubicin-induced cognitive impairment and hippocampal oxidative, inflammatory, and apoptotic alterations in rats. [PDF]

Front Pharmacol
Alresheedi MM, Aldubayan MA.
europepmc   +1 more source

Efficacy of sacubitril/valsartan combined with dapagliflozin in treating patients with heart failure and diabetes after an acute myocardial infarction

Lifang Zhang, Xiuying Tang, Runjun Li, Jinxia Niu, Jie Gong   +4 more
openalex   +2 more sources

Theuse of LCZ-696(Sacubitril/Valsartan) and SGLT2inhibitors: A Real World Experience in a Rural African Patient with Heart Failure with Reduced Ejection Fraction (HFrEF). A Case Series

, 2023
Dominick Mkombozi Raphael, Gerald Jamberi Makuka, Abdu Hussein Mogella, Beatrice Kabuka, Rosemary Thadeus Mushi, Collins Boamah   +5 more
openalex   +2 more sources

Dose-dependent renoprotective effects of sacubitril/valsartan in heart failure: a retrospective study. [PDF]

Ren Fail
Kato T, Nakano Y, Yasukawa N, Oonishi M, Hamada Y.   +4 more
europepmc   +1 more source

Impact of early in-hospital initiation of sacubitril/valsartan on left ventricular reverse remodelling in acute heart failure. [PDF]

Eur Heart J Cardiovasc Pharmacother
Takahashi T, Kusunose K, Imai T, Furukawa Y, Okada T, Kadokami T, Kanzaki Y, Matsuda H, Mizukoshi K, Kida K, Matsue Y, Sata M, Tanaka A, Node K.   +13 more
europepmc   +1 more source